These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 34436595)

  • 1. Mucosal vaccines: wisdom from now and then.
    Kiyono H; Yuki Y; Nakahashi-Ouchida R; Fujihashi K
    Int Immunol; 2021 Nov; 33(12):767-774. PubMed ID: 34436595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mucosal immune system: From dentistry to vaccine development.
    Kiyono H; Azegami T
    Proc Jpn Acad Ser B Phys Biol Sci; 2015; 91(8):423-39. PubMed ID: 26460320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New horizon of mucosal immunity and vaccines.
    Takahashi I; Nochi T; Yuki Y; Kiyono H
    Curr Opin Immunol; 2009 Jun; 21(3):352-8. PubMed ID: 19493665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges in developing mucosal vaccines and antibodies against infectious diarrhea in children.
    Tokuhara D
    Pediatr Int; 2018 Mar; 60(3):214-223. PubMed ID: 29290097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.
    Nakahashi-Ouchida R; Yuki Y; Kiyono H
    Hum Vaccin Immunother; 2018; 14(9):2189-2193. PubMed ID: 29624474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational application of nanoadjuvant for mucosal vaccine delivery system.
    Dewangan HK
    J Immunol Methods; 2020; 481-482():112791. PubMed ID: 32387695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in mucosal vaccines for the control of infectious diseases.
    Azegami T; Yuki Y; Kiyono H
    Int Immunol; 2014 Sep; 26(9):517-28. PubMed ID: 24914172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal vaccines: solutions for respiratory infectious diseases.
    Nakahashi-Ouchida R; Fujihashi K; Kurashima Y; Yuki Y; Kiyono H
    Trends Mol Med; 2023 Feb; 29(2):124-140. PubMed ID: 36435633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucosal immunosenescence: new developments and vaccines to control infectious diseases.
    Fujihashi K; Kiyono H
    Trends Immunol; 2009 Jul; 30(7):334-43. PubMed ID: 19540811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mucosal immune system: from control of inflammation to protection against infections.
    Kaiserlian D; Cerf-Bensussan N; Hosmalin A
    J Leukoc Biol; 2005 Aug; 78(2):311-8. PubMed ID: 15894590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New generation of oral mucosal vaccines targeting dendritic cells.
    Owen JL; Sahay B; Mohamadzadeh M
    Curr Opin Chem Biol; 2013 Dec; 17(6):918-24. PubMed ID: 23835515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanogel-based nasal vaccines for infectious and lifestyle-related diseases.
    Azegami T; Yuki Y; Nakahashi R; Itoh H; Kiyono H
    Mol Immunol; 2018 Jun; 98():19-24. PubMed ID: 29096936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of oral vaccines].
    Matsubara A; Shimizu Y; Karamatsu K; Yasutomi Y
    Nihon Rinsho; 2008 Oct; 66(10):1873-8. PubMed ID: 18939484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal and pulmonary vaccine delivery using particulate carriers.
    Jia Y; Krishnan L; Omri A
    Expert Opin Drug Deliv; 2015 Jun; 12(6):993-1008. PubMed ID: 25952104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunization: a review of strategies and challenges.
    Patel H; Yewale C; Rathi MN; Misra A
    Crit Rev Ther Drug Carrier Syst; 2014; 31(4):273-303. PubMed ID: 25072196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems.
    Boyaka PN
    J Immunol; 2017 Jul; 199(1):9-16. PubMed ID: 28630108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal delivery of vaccine antigens and its advantages in pediatrics.
    De Magistris MT
    Adv Drug Deliv Rev; 2006 Apr; 58(1):52-67. PubMed ID: 16516335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mucosal immune system for vaccine development.
    Lamichhane A; Azegamia T; Kiyonoa H
    Vaccine; 2014 Nov; 32(49):6711-23. PubMed ID: 25454857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salivary IgA enhancement strategy for development of a nasal-spray anti-caries mucosal vaccine.
    Yan H
    Sci China Life Sci; 2013 May; 56(5):406-13. PubMed ID: 23633072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in mucosal vaccine development.
    Chen H
    J Control Release; 2000 Jul; 67(2-3):117-28. PubMed ID: 10825547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.